In his weekly clinical update Dr. Griffin discusses high points of the multi-national monkeypox outbreaks, monkeypox virus genome mutations, possible occupational infection of healthcare workers with monkeypox virus, rates of monkeypox cases by vaccination status, protection of SARS-CoV-2 infection against reinfection, Paxlovid significantly reduces COVID-19 hospitalizations and deaths, and rebound in COVID19 with and without Paxlovid treatment.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Research assistant position with Amy Rosenfeld (pdf)
• Support MicrobeTV with a Spike t-shirt at Vaccinated.US
• Multi-National Monkeypox outbreak (CDC)
• Mutation of the Monkeypox Virus (Nature)
• Occupational infection of Healthcare workers with Monkeypox (CDC)
• Rates of Monkeypox cases by vaccination status (CDC)
• Protection of SARS-CoV-2 natural infection against reinfection (CMI)
• PAXLOVID patient eligibility screening checklist (FDA)
• Paxlovid reduces COVID19 hospitalizations & deaths (EPIC)
• Paxlovid rebound in COVID19 (NEJM)
• Remdesivir fact sheet for providers (Veklury) 
• Bebtelovimab fact sheet for providers (FDA)
• Dr. Griffin’s treatment guide (pdf)
• Contribute to Floating Doctors fundraiser at PWB
• Letters read on TWiV 943
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]